Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 1160,"Vingsbo-Lundberg C, et al., Nat Genet 1998 Dec;20(4):401-4",joint integrity trait,,RS:0000208,E3/ZtmRhd,both,0 days,25,,CMO:0001453,percentage of study population developing experimental arthritis during a period of time,,,,0,%,,,MMO:0000163,in vivo visual assessment,,4838400.0,,,,,pristane (150 ul) (for 56 days),69592,pristane (150 ul) (for 56 days) 1159,"Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83",joint integrity trait,,RS:0000208,E3/ZtmRhd,both,98 days to 56 days,23,,CMO:0001453,percentage of study population developing experimental arthritis during a period of time,,,,9,%,,,MMO:0000163,in vivo visual assessment,,0.0,,,,,pristane (150 ul) ,69664,pristane (150 ul) 1164,"Olofsson P, et al., J Immunol 2003 Jul 1;171(1):407-16.",joint integrity trait,,RS:0000208,E3/ZtmRhd,both,84 days to 56 days,10,,CMO:0001453,percentage of study population developing experimental arthritis during a period of time,,,,0,%,,,MMO:0000163,in vivo visual assessment,,2419200.0,,,,,pristane (150 ul) ,69839,pristane (150 ul) 1159,"Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83",joint integrity trait,,RS:0000208,E3/ZtmRhd,both,98 days to 56 days,23,,CMO:0001450,post-insult time to onset of experimental arthritis,,,,38,d,1.2511,6.0,MMO:0000163,in vivo visual assessment,,0.0,,,,,pristane (150 ul) ,69672,pristane (150 ul) 1160,"Vingsbo-Lundberg C, et al., Nat Genet 1998 Dec;20(4):401-4",joint integrity trait,,RS:0000208,E3/ZtmRhd,both,0 days,25,,CMO:0001456,percentage of study population developing chronic experimental arthritis during a period of time,,,,0,%,,,MMO:0000163,in vivo visual assessment,,1.0368E7,,,,,pristane (150 ul) (for 120 days),69966,pristane (150 ul) (for 120 days) 1159,"Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83",joint integrity trait,,RS:0000208,E3/ZtmRhd,both,98 days to 56 days,23,,CMO:0001456,percentage of study population developing chronic experimental arthritis during a period of time,,,,0,%,,,MMO:0000163,in vivo visual assessment,,0.0,,,,,pristane (150 ul) ,69680,pristane (150 ul) 1164,"Olofsson P, et al., J Immunol 2003 Jul 1;171(1):407-16.",joint integrity trait,,RS:0000208,E3/ZtmRhd,both,84 days to 56 days,10,,CMO:0001460,arthritic paw count,,,,0,,,,MMO:0000163,in vivo visual assessment,,2419200.0,,,,,pristane (150 ul) ,69841,pristane (150 ul)